S-4321

N/A

Report date: 2026/03/09 20:02:04

Base Information

Drug NameS-4321
Drug Alias NamePD-1-FcγRIIb (Seismic Therapeutics)S-4321
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionProgrammed cell death protein 1 agonistsLow affinity immunoglobulin gamma Fc region receptor II-b modulators
TargetsProgrammed cell death protein 1Low affinity immunoglobulin gamma Fc region receptor II-b
Therapy Area/IndicationsAutoimmune DiseasesImmune System DiseasesPsoriasis +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSeismic Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSeismic Therapeutic AU Pty LtdSeismic Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesImmune System DiseasesPsoriasis +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A